ES2658037T3 - Sistema de administración transdérmica - Google Patents
Sistema de administración transdérmica Download PDFInfo
- Publication number
- ES2658037T3 ES2658037T3 ES14727614.1T ES14727614T ES2658037T3 ES 2658037 T3 ES2658037 T3 ES 2658037T3 ES 14727614 T ES14727614 T ES 14727614T ES 2658037 T3 ES2658037 T3 ES 2658037T3
- Authority
- ES
- Spain
- Prior art keywords
- mesh
- hydrogel
- solution
- sodium nitrite
- blood flow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000017 hydrogel Substances 0.000 abstract description 18
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 abstract description 11
- -1 hydrogen ions Chemical class 0.000 abstract description 6
- 239000013543 active substance Substances 0.000 abstract description 3
- 239000001257 hydrogen Substances 0.000 abstract description 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 3
- 150000002500 ions Chemical class 0.000 abstract 1
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 32
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 24
- 235000010288 sodium nitrite Nutrition 0.000 description 16
- 230000017531 blood circulation Effects 0.000 description 14
- 239000010410 layer Substances 0.000 description 12
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 208000008960 Diabetic foot Diseases 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 5
- 229910021641 deionized water Inorganic materials 0.000 description 5
- 229940068196 placebo Drugs 0.000 description 5
- 239000000902 placebo Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 239000011247 coating layer Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 229960004194 lidocaine Drugs 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920006264 polyurethane film Polymers 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- XMLYCEVDHLAQEL-UHFFFAOYSA-N 2-hydroxy-2-methyl-1-phenylpropan-1-one Chemical compound CC(C)(O)C(=O)C1=CC=CC=C1 XMLYCEVDHLAQEL-UHFFFAOYSA-N 0.000 description 1
- RIWRBSMFKVOJMN-UHFFFAOYSA-N 2-methyl-1-phenylpropan-2-ol Chemical compound CC(C)(O)CC1=CC=CC=C1 RIWRBSMFKVOJMN-UHFFFAOYSA-N 0.000 description 1
- IRLPACMLTUPBCL-KQYNXXCUSA-N 5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O IRLPACMLTUPBCL-KQYNXXCUSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 125000004386 diacrylate group Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/009—Materials resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/114—Nitric oxide, i.e. NO
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201309092 | 2013-05-20 | ||
| GB201309092A GB201309092D0 (en) | 2013-05-20 | 2013-05-20 | Transdermal delivery system |
| PCT/GB2014/051544 WO2014188175A1 (en) | 2013-05-20 | 2014-05-20 | Transdermal delivery system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2658037T3 true ES2658037T3 (es) | 2018-03-08 |
Family
ID=48747065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES14727614.1T Active ES2658037T3 (es) | 2013-05-20 | 2014-05-20 | Sistema de administración transdérmica |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10010648B2 (https=) |
| EP (1) | EP2908873B1 (https=) |
| JP (1) | JP6446035B2 (https=) |
| CN (1) | CN105431175B (https=) |
| AU (1) | AU2014270116B2 (https=) |
| DK (1) | DK2908873T3 (https=) |
| ES (1) | ES2658037T3 (https=) |
| GB (1) | GB201309092D0 (https=) |
| HR (1) | HRP20180079T1 (https=) |
| HU (1) | HUE035847T2 (https=) |
| LT (1) | LT2908873T (https=) |
| NO (1) | NO2908873T3 (https=) |
| PL (1) | PL2908873T3 (https=) |
| PT (1) | PT2908873T (https=) |
| RS (1) | RS56833B1 (https=) |
| SI (1) | SI2908873T1 (https=) |
| SM (1) | SMT201800030T1 (https=) |
| WO (1) | WO2014188175A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201420761D0 (en) | 2014-11-21 | 2015-01-07 | Edixomed Ltd And First Water Ltd | Dressing system |
| GB201520990D0 (en) * | 2015-11-27 | 2016-01-13 | Edixomed Ltd | Dressing system |
| TWI605843B (zh) * | 2016-12-21 | 2017-11-21 | 嘉藥學校財團法人嘉南藥理大學 | 氣相經皮吸收系統 |
| WO2019166572A1 (en) | 2018-02-28 | 2019-09-06 | Pharming Intellectual Property B.V. | Pharmaceutical system for transdermal administration of a c1 -esterase inhibitor |
| WO2020016758A1 (en) * | 2018-07-16 | 2020-01-23 | Systagenix Wound Management, Limited | Nitric oxide producing collagen/orc dressing |
| CA3126076A1 (en) * | 2019-01-11 | 2020-07-30 | Noxsano Inc. | Electrochemical gasotransmitter generating compositions and bimetallic cells for the generation of gasotransmitters |
| BR112021023832A8 (pt) | 2019-06-04 | 2023-02-28 | Thirty Holdings Ltd | Métodos e composições para geração de óxido nítrico e usos dos mesmos |
| BR112021023632A2 (pt) * | 2019-06-04 | 2022-04-19 | Thirty Respiratory Ltd | Métodos e composições para gerar óxido nítrico e usos do mesmo para entregar óxido nítrico através do trato respiratório |
| GB202004868D0 (en) * | 2020-04-02 | 2020-05-20 | Smith & Nephew | Wound care compositions and methods of preparation thereof |
| WO2021198470A1 (en) * | 2020-04-02 | 2021-10-07 | T.J.Smith And Nephew,Limited | Wound dressing |
| JP2023526583A (ja) | 2020-04-23 | 2023-06-22 | サーティー レスピラトリー リミテッド | 結核を治療及び抑制するための方法及び組成物 |
| US20240016831A1 (en) | 2020-04-23 | 2024-01-18 | Thirty Respiratory Limited | Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2 |
| CN113101053A (zh) * | 2021-03-30 | 2021-07-13 | 上海健康医学院 | 一种可释放一氧化氮的创伤敷料 |
| US12514756B1 (en) | 2024-10-08 | 2026-01-06 | Covidien Lp | Dermal patch and systems, kits, and methods associated therewith |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA837139B (en) | 1982-10-26 | 1984-05-30 | Kennecott Corp | Two high hot rolling mill process and narrow strip product |
| EP0139127A1 (en) | 1983-08-22 | 1985-05-02 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Transdermal drug delivery device and its preparation |
| AU5180199A (en) | 1998-07-31 | 2000-02-21 | First Water Limited | Bioadhesive compositions and biomedical electrodes containing them |
| GB9905425D0 (en) | 1999-03-09 | 1999-05-05 | Queen Mary & Westfield College | Pharmaceutical composition |
| GB0021317D0 (en) * | 2000-08-30 | 2000-10-18 | Queen Mary & Westfield College | Transdermal pharmaceutical delivery composition |
| CA2323382C (en) | 2000-10-17 | 2004-04-13 | Pharma Mag Inc. | Wound dressing |
| GB0715556D0 (en) | 2007-08-09 | 2007-09-19 | Insense Ltd | Improvements relating to skin dressings |
| GB0715554D0 (en) | 2007-08-09 | 2007-09-19 | Insense Ltd | Improvements relating to skin dressings |
| US20100055161A1 (en) | 2008-08-27 | 2010-03-04 | Dong June Ahn | Hydrogel face mask for delivering skin care agents |
| CA2777066C (en) | 2009-10-14 | 2020-02-18 | TheraVasc, LLC | Pharmaceutical formulations of nitrite and uses thereof |
| JP2013515021A (ja) | 2009-12-22 | 2013-05-02 | リスホスピタレト，コペンハーゲン ユニバーシティ ホスピタル | 創傷治療製品 |
| GB201309091D0 (en) * | 2013-05-20 | 2013-07-03 | Edixomed Ltd | Dressing system |
-
2013
- 2013-05-20 GB GB201309092A patent/GB201309092D0/en not_active Ceased
-
2014
- 2014-05-20 WO PCT/GB2014/051544 patent/WO2014188175A1/en not_active Ceased
- 2014-05-20 DK DK14727614.1T patent/DK2908873T3/en active
- 2014-05-20 RS RS20180044A patent/RS56833B1/sr unknown
- 2014-05-20 AU AU2014270116A patent/AU2014270116B2/en active Active
- 2014-05-20 SM SM20180030T patent/SMT201800030T1/it unknown
- 2014-05-20 PT PT147276141T patent/PT2908873T/pt unknown
- 2014-05-20 US US14/892,218 patent/US10010648B2/en active Active
- 2014-05-20 LT LTEP14727614.1T patent/LT2908873T/lt unknown
- 2014-05-20 CN CN201480029019.7A patent/CN105431175B/zh active Active
- 2014-05-20 HU HUE14727614A patent/HUE035847T2/en unknown
- 2014-05-20 SI SI201430560T patent/SI2908873T1/en unknown
- 2014-05-20 PL PL14727614T patent/PL2908873T3/pl unknown
- 2014-05-20 ES ES14727614.1T patent/ES2658037T3/es active Active
- 2014-05-20 HR HRP20180079TT patent/HRP20180079T1/hr unknown
- 2014-05-20 JP JP2016514478A patent/JP6446035B2/ja active Active
- 2014-05-20 NO NO14727614A patent/NO2908873T3/no unknown
- 2014-05-20 EP EP14727614.1A patent/EP2908873B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RS56833B1 (sr) | 2018-04-30 |
| JP2016518458A (ja) | 2016-06-23 |
| US10010648B2 (en) | 2018-07-03 |
| EP2908873A1 (en) | 2015-08-26 |
| PT2908873T (pt) | 2018-01-23 |
| CN105431175B (zh) | 2018-12-28 |
| PL2908873T3 (pl) | 2018-06-29 |
| US20160089473A1 (en) | 2016-03-31 |
| EP2908873B1 (en) | 2017-10-18 |
| CN105431175A (zh) | 2016-03-23 |
| AU2014270116B2 (en) | 2017-12-21 |
| DK2908873T3 (en) | 2018-01-22 |
| GB201309092D0 (en) | 2013-07-03 |
| WO2014188175A1 (en) | 2014-11-27 |
| AU2014270116A1 (en) | 2015-12-10 |
| SMT201800030T1 (it) | 2018-03-08 |
| JP6446035B2 (ja) | 2018-12-26 |
| HUE035847T2 (en) | 2018-05-28 |
| HRP20180079T1 (hr) | 2018-04-06 |
| NO2908873T3 (https=) | 2018-03-17 |
| LT2908873T (lt) | 2018-02-12 |
| SI2908873T1 (en) | 2018-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2658037T3 (es) | Sistema de administración transdérmica | |
| ES2661643T3 (es) | Sistema de apósito | |
| CN104755128B (zh) | 视黄酸微针 | |
| ES2641091T3 (es) | Composición de vitamina D | |
| US20200179558A1 (en) | Dressing System | |
| ES2683006T3 (es) | Parche no acuoso | |
| CN102078636A (zh) | 含重组人表皮生长因子的水凝胶敷料及其制备方法与应用 | |
| JP6104390B2 (ja) | ミクロスフェアを含む改良された創傷治癒用組成物 | |
| Tan et al. | Vasomodulation of peripheral blood flow by focused ultrasound potentiates improvement of diabetic neuropathy | |
| KR101540318B1 (ko) | 수면마취용 구강점막 부착형 패치 및 이의 제조방법 | |
| AR074820A1 (es) | Composicion de microparticulas biocompatibles de acido alginico para la liberacion controlada de principios activos por via intravenosa | |
| WO2017220845A1 (es) | Composiciones para el tratamiento de estrías y úlceras de origen isquémico | |
| CN105343119B (zh) | 环磷酸腺苷或其衍生物在手术后网膜下出血中的应用 | |
| CN103877004A (zh) | 一种复方利培酮皮下埋植缓释剂及其制备方法 | |
| BR112019005722B1 (pt) | Emplastro para aplicação na pele de um indivíduo e uso do emplastro |